Literature DB >> 19596780

Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis.

Kyra A Oswald-Richter1, Daniel A Culver, Charlene Hawkins, Rana Hajizadeh, Susamma Abraham, Bryan E Shepherd, Cathy A Jenkins, Marc A Judson, Wonder P Drake.   

Abstract

Considerable evidence supports the concept that CD4(+) T cells are important in sarcoidosis pathogenesis, but the antigens responsible for the observed Th1 immunophenotype remain elusive. The epidemiologic association with bioaerosols and the presence of granulomatous inflammation support consideration of mycobacterial antigens. To explore the role of mycobacterial antigens in sarcoidosis immunopathogenesis, we assessed the immune recognition of mycobacterial antigens, the 6-kDa early secreted antigenic protein (ESAT-6) and catalase-peroxidase (KatG), by T cells derived from bronchoalveolar lavage (BAL) fluid obtained during diagnostic bronchoscopy. We report the presence of antigen-specific recognition of ESAT-6 and KatG in T cells from BAL fluid of 32/44 sarcoidosis subjects, compared to 1/27 controls (P < 0.0001). CD4(+) T cells were primarily responsible for immune recognition (32/44 sarcoidosis subjects), although CD8(+) T-cell responses were observed (25/41 sarcoidosis subjects). Recognition was significantly absent from BAL fluid cells of patients with other lung diseases, including infectious granulomatous diseases. Blocking of Toll-like receptor 2 reduced the strength of the observed immune response. The presence of immune responses to mycobacterial antigens in cells from BAL fluid used for sarcoidosis diagnosis suggests a strong association between mycobacteria and sarcoidosis pathogenesis. Inhibition of immune recognition with monoclonal antibody against Toll-like receptor 2 suggests that induction of innate immunity by mycobacteria contributes to the polarized Th1 immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19596780      PMCID: PMC2738026          DOI: 10.1128/IAI.00142-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

Review 1.  CD8+ T cell effector mechanisms in resistance to infection.

Authors:  J T Harty; A R Tvinnereim; D W White
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Mycobacterium tuberculosis complex and mycobacterial heat shock proteins in lymph node tissue from patients with pulmonary sarcoidosis.

Authors:  Anna Dubaniewicz; Miroslawa Dubaniewicz-Wybieralska; Adam Sternau; Zofia Zwolska; Ewa Izycka-Swieszewska; Ewa Augustynowicz-Kopec; Jaroslaw Skokowski; Mahavir Singh; Lech Zimnoch
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

Review 4.  How flow cytometry is changing the study of TB immunology and clinical diagnosis.

Authors:  Stephan Fuhrmann; Mathias Streitz; Florian Kern
Journal:  Cytometry A       Date:  2008-11       Impact factor: 4.355

5.  Seasonal clustering of sarcoidosis presenting with erythema nodosum.

Authors:  M L Wilsher
Journal:  Eur Respir J       Date:  1998-11       Impact factor: 16.671

6.  CD4(+) and CD8(+) T cells kill intracellular Mycobacterium tuberculosis by a perforin and Fas/Fas ligand-independent mechanism.

Authors:  D H Canaday; R J Wilkinson; Q Li; C V Harding; R F Silver; W H Boom
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

7.  Epidemiology of sarcoidosis in Japan.

Authors:  T Morimoto; A Azuma; S Abe; J Usuki; S Kudoh; K Sugisaki; M Oritsu; T Nukiwa
Journal:  Eur Respir J       Date:  2007-10-24       Impact factor: 16.671

8.  Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis.

Authors:  Simon M Barry; Marc C Lipman; Barbara Bannister; Margaret A Johnson; George Janossy
Journal:  J Infect Dis       Date:  2002-12-19       Impact factor: 5.226

9.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

Authors:  Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

10.  Molecular analysis of sarcoidosis tissues for mycobacterium species DNA.

Authors:  Wonder Puryear Drake; Zhiheng Pei; David T Pride; Robert D Collins; Timothy L Cover; Martin J Blaser
Journal:  Emerg Infect Dis       Date:  2002-11       Impact factor: 6.883

View more
  35 in total

Review 1.  A concise review of pulmonary sarcoidosis.

Authors:  Robert P Baughman; Daniel A Culver; Marc A Judson
Journal:  Am J Respir Crit Care Med       Date:  2010-10-29       Impact factor: 21.405

2.  Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.

Authors:  Carmen M Swaisgood; Kyra Oswald-Richter; Stephen D Moeller; Jennifer M Klemenc; Lisa M Ruple; Carol F Farver; John M Drake; Daniel A Culver; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2010-03-26       Impact factor: 6.914

Review 3.  Evidence for mycobacteria in sarcoidosis.

Authors:  Isaac Brownell; Francisco Ramírez-Valle; Miguel Sanchez; Stephen Prystowsky
Journal:  Am J Respir Cell Mol Biol       Date:  2011-06-09       Impact factor: 6.914

4.  Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis Model.

Authors:  Anagha Malur; Arjun Mohan; Robert A Barrington; Nancy Leffler; Amrita Malur; Barbara Muller-Borer; Gina Murray; Kim Kew; Chuanzhen Zhou; Josh Russell; Jacob L Jones; Christopher J Wingard; Barbara P Barna; Mary Jane Thomassen
Journal:  Am J Respir Cell Mol Biol       Date:  2019-08       Impact factor: 6.914

Review 5.  Neuro-ophthalmic sarcoidosis.

Authors:  Robert P Baughman; Kenneth L Weiss; Karl C Golnik
Journal:  Eye Brain       Date:  2012-03-13

Review 6.  The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques.

Authors:  Hasib Ahmadzai; Denis Wakefield; Paul S Thomas
Journal:  Inflammopharmacology       Date:  2011-02-13       Impact factor: 4.473

7.  Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL.

Authors:  Kyra A Oswald-Richter; Dia C Beachboard; Erin H Seeley; Susamma Abraham; Bryan E Shepherd; Cathy A Jenkins; Daniel A Culver; Richard M Caprioli; Wonder P Drake
Journal:  J Clin Immunol       Date:  2012-05-03       Impact factor: 8.317

8.  Programmed Death-1 Inhibition of Phosphatidylinositol 3-Kinase/AKT/Mechanistic Target of Rapamycin Signaling Impairs Sarcoidosis CD4+ T Cell Proliferation.

Authors:  Lindsay J Celada; Joseph E Rotsinger; Anjuli Young; Guzel Shaginurova; Debresha Shelton; Charlene Hawkins; Wonder P Drake
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

9.  Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis.

Authors:  Kyra A Oswald-Richter; Dia C Beachboard; Xiaoyan Zhan; Christa F Gaskill; Susamma Abraham; Cathy Jenkins; Daniel A Culver; Wonder Drake
Journal:  Respir Res       Date:  2010-11-23

10.  Sarcoidosis Th17 cells are ESAT-6 antigen specific but demonstrate reduced IFN-γ expression.

Authors:  Bradley W Richmond; Kristen Ploetze; Joan Isom; Isfahan Chambers-Harris; Nicole A Braun; Thyneice Taylor; Susamma Abraham; Yolanda Mageto; Dan A Culver; Kyra A Oswald-Richter; Wonder P Drake
Journal:  J Clin Immunol       Date:  2012-10-18       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.